Policy Views
Discover our articles
Posted on 04.11.2021
Heart failure – the time to act is now
By Markus Schwertfeger, Senior Global Medical Affairs Lead Roche Diagnostics International
Posted on 13.10.2021
How innovation is transforming stroke care?
By Alenka Brzulja, Vice President of Cardiovascular & Specialty Solutions EMEA, Johnson & Johnson Medical Devices Companies
Posted on 12.10.2021
How can orthopaedic waiting lists be tackled?
By Torbjorn Skold, Vice President EMEA DePuy Synthes Joint Reconstruction
Posted on 27.09.2021
New EU Alliance will put cardiovascular health in the spotlight
By Jean-Luc Lemercier, Corporate Vice President Edwards Lifesciences, EMEA, Canada, Latin America and JAPAC & Chair of the Cardiovascular Sector Group of MedTech Europe
Posted on 23.09.2021
Global approach needed to remote audits
By Emmett Devereux, Director Government and Regulatory Affairs, Cook Medical EMEA
Posted on 27.07.2021
This is no time to further unsettle EU medtech legislation
By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 12.07.2021
Is medical technology innovation leaving Europe?
By Julia Steckeler, CEO - MedicalMountains GmbH
Posted on 01.07.2021
Ethical collaborations: new guidelines help companies partner with patient organisations
By Clarisse Aillet, Medical Education Consultant
Posted on 29.06.2021
Reimagining healthcare delivery in a new era of surgery
By Hani Abouhalka, Company Group Chairman - Johnson & Johnson Medical Devices Companies Europe, Middle East & Africa (EMEA)
Posted on 23.06.2021
MedTech: a partner in building a research-oriented, innovative, and resilient Europe
By Patrick Boisseau, Director Research and Innovation, MedTech Europe
Posted on 27.05.2021
The need for an EU Action Plan for better cardiovascular health
By Jean-Luc Lemercier, Corporate Vice President Edwards Lifesciences, EMEA, Canada, Latin America and JAPAC & Chair of the Cardiovascular Sector Group of MedTech Europe

